Supreme Court To Hear Generic Drug Preemption Cases Against Advice Of Solicitor General
This article was originally published in The Pink Sheet Daily
Executive Summary
The court agreed to review three cases in which generic manufacturers of Reglan (metoclopramide) were held responsible for warning about the risk of tardive dyskinesia.
You may also be interested in...
Generic Industry Faces Uphill Battle In Preemption Case Before Supreme Court
Generic companies appear to be the underdogs as they head to the Supreme Court to argue they should not be held liable for inadequate label warnings.
Generic Industry Faces Uphill Battle In Preemption Case Before Supreme Court
Generic companies appear to be the underdogs as they head to the Supreme Court to argue they should not be held liable for inadequate label warnings.
High Court’s Vaccines Ruling Gives Drug Makers Hope For Design Defect Claim Pre-emption
The U.S. Supreme Court’s ruling that vaccine design defect claims are statutorily pre-empted could provide a potential defense in certain pharmaceutical product liability lawsuits, industry attorneys said.